Yuchi Han, MD
Cardiovascular Disease · Columbus, OHNPI 1164498291
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,980 of the $21,002 with a category attached, or 61.8%. GE HealthCare accounts for 62.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $10,915 and has fallen 96.7% since, to $357 in 2023.
Across 17 payments — averaging $1235.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$13K
- Vertex$7K
- Siemens Medical Solutions USA, Inc.$432
- Medtronic$179
Across 6 payments — averaging $15,215 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$75K
- Gilead$13K
- Siemens Medical Solutions USA, Inc.$3K
What the payments were for
- Consulting fees$7,26035%
- Speaking & faculty fees$12,98062%
- Food & beverage$7624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 12 | $13,131 |
| Vertex | 1 | $7,260 |
| Siemens Medical Solutions USA, Inc. | 3 | $432 |
| Medtronic | 1 | $179 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTISON$12,540
- ENDURANT IIS$179
How this compares
$21,002 in reported general payments places this provider in the 85th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $15,557 |
| Metoprolol Succinate | 33 | $587 |
| Atorvastatin Calcium | 29 | $252 |
| Losartan Potassium | 21 | $223 |
| Furosemide | 19 | $97 |
| Metoprolol Tartrate | 13 | $96 |
| Carvedilol | 18 | $78 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Columbus
- Jayanta MukherjeeColumbus$227K
- Steven DeanColumbus$153K
- Manmohan KatapadiColumbus$124K
- David RichardsColumbus$55K
- Akira WadaColumbus$49K
- Paul HarnishColumbus$49K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.